A preliminary analysis of the balance between Th1 and Th2 cells after CD34+ cell-selected autologous PBSC transplantation

被引:3
作者
Endo, T
Sato, N
Koizumi, K
Nishio, M
Fujimoto, K
Yamamoto, S
Sakai, T
Bohgaki, T
Sawada, K
Koike, T
机构
[1] Hokkaido Univ, Grad Sch Med, Dept Internal Med 2, Kita Ku, Sapporo, Hokkaido 0608638, Japan
[2] Hokkaido Univ, Hosp Med, Blood Transfus Serv, Sapporo, Hokkaido, Japan
[3] Akita Univ, Sch Med, Dept Internal Med 3, Akita 010, Japan
关键词
autologous PBSC transplantation; CD34; positive selection; Th1; Th2;
D O I
10.1080/14653240410004907
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Background CD34(+) cell-selected autologous PBSC transplantation (CD34(+) APBSCT) is a procedure used for the treatment of patients with malignant disease that is intended to eliminate residual tumor cells from autologous grafts. However, frequent infectious complications after CD34(+) APBSCT can occur. A delay of recovery of the absolute number of CD4(+) T cells after transplantation was reported to be one disadvantageous factor. As data on T-cell function after CD34(+) APBSCT are scanty, we analyzed changes in T-helper cell 1 (Th1) and T-helper cell 2 (Th2) after CD34(+) APBSCT to evaluate immune reconstitution. Methods Twelve patients underwent APBSCT (CD34(+) APBSCT group, n = 4, and unselected APBSCT, n = 8). Peripheral blood (PB) samples were obtained at 2, 4, 8, 12 and 16 weeks after the transplantation. The dynamics of the Th1 and Th2 were analyzed at a single-cell level, using flow cytometry. Results In the CD34(+) APBSCT group, not only the absolute count of CD4(+) T cells but also the proportion of Th1 cells in CD4(+) T cells and the ratio of Th1 to Th2 after transplantation were significantly decreased at 2 and 4 weeks after transplantation compared with findings in the unselected APBSCT group. Discussion We suggest that higher rates of infectious complications after CD34(+) APBSCT may be due to the inability of residual T cells from the CD34(+) cell selection to generate mature T cells that function adequately against infection. Although further study would be required, our preliminary data provide some information on the immune reconstitution after CD34(+) APBSCT and differentiation of T lymphocytes into Th1 and Th2 in vivo.
引用
收藏
页码:337 / 343
页数:7
相关论文
共 33 条
[21]   HETEROGENEITY OF INTRACELLULAR CYTOKINE SYNTHESIS AT THE SINGLE-CELL LEVEL IN POLARIZED T-HELPER-1 AND T-HELPER-2 POPULATIONS [J].
OPENSHAW, P ;
MURPHY, EE ;
HOSKEN, NA ;
MAINO, V ;
DAVIS, K ;
MURPHY, K ;
OGARRA, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (05) :1357-1367
[22]   Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment [J].
Ouyang, WJ ;
Löhning, M ;
Gao, ZG ;
Assenmacher, M ;
Ranganath, S ;
Radbruch, A ;
Murphy, KM .
IMMUNITY, 2000, 12 (01) :27-37
[23]   Immune reconstitution after transplantation of autologous peripheral CD34+ cells:: analysis of predictive factors and comparison with unselected progenitor transplants [J].
Rutella, S ;
Rumi, C ;
Laurenti, L ;
Pierelli, L ;
Sora, F ;
Sica, S ;
Leone, G .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 108 (01) :105-115
[24]   Transplantation of autologous peripheral blood progenitor cells: Impact of CD34-cell selection on immunological reconstitution [J].
Rutella, S ;
Pierelli, L ;
Sica, S ;
Rumi, C ;
Leone, G .
LEUKEMIA & LYMPHOMA, 2001, 42 (06) :1207-1220
[25]   TRANSPLANTATION OF CD34(+) PERIPHERAL-BLOOD PROGENITOR CELLS AFTER HIGH-DOSE CHEMOTHERAPY FOR PATIENTS WITH ADVANCED MULTIPLE-MYELOMA [J].
SCHILLER, G ;
VESCIO, R ;
FREYTES, C ;
SPITZER, G ;
SAHEBI, F ;
LEE, M ;
WU, CH ;
CAO, J ;
LEE, JC ;
HONG, CH ;
LICHTENSTEIN, A ;
LILL, M ;
HALL, J ;
BERENSON, R ;
BERENSON, J .
BLOOD, 1995, 86 (01) :390-397
[26]   Interstitial pneumonitis in bone marrow transplant recipients is associated with local production of TH2-type cytokines and lack of T cell-mediated cytotoxicity [J].
Sparrelid, E ;
Emanuel, D ;
Fehniger, T ;
Andersson, U ;
Andersson, J .
TRANSPLANTATION, 1997, 63 (12) :1782-1789
[27]   Mobilization of peripheral blood progenitor cells following CHOP treatment combined with delayed granulocyte colony-stimulating factor administration in patients with non-Hodgkin's lymphoma [J].
Takano, H ;
Sawada, K ;
Sato, N ;
Notoya, A ;
Tarumi, T ;
Hirayama, S ;
Koizumi, K ;
Takahashi, TA ;
Sekiguchi, S ;
Koike, T .
LEUKEMIA & LYMPHOMA, 1996, 21 (5-6) :473-478
[28]  
Takeshima M, 1999, INT J HEMATOL, V70, P193
[29]   The important balance between cytokines derived from type 1 and type 2 helper T cells in the control of graft-versus-host disease [J].
Tanaka, J ;
Imamura, M ;
Kasai, M ;
Hashino, S ;
Kobayashi, S ;
Noto, S ;
Higa, T ;
Sakurada, K ;
Asaka, M .
BONE MARROW TRANSPLANTATION, 1997, 19 (06) :571-576
[30]   A pilot study of a response oriented chemotherapeutic regimen combined with autologous peripheral blood progenitor cell transplantation in aggressive non-Hodgkin's lymphoma [J].
Tarumi, T ;
Sawada, K ;
Koizumi, K ;
Takano, H ;
Fukada, Y ;
Nishio, M ;
Fujie, T ;
Ohnishi, K ;
Kohno, M ;
Sato, N ;
Sekiguchi, S ;
Koike, T .
LEUKEMIA & LYMPHOMA, 1999, 34 (3-4) :361-371